![Eric J. Sherman, MD](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/577/image/sherman-eric.jpg?h=10d202d3)
Eric J. Sherman, MD
Head and Neck Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Associate Attending Physician
I am a medical oncologist dedicated to improving the lives of patients with head and neck cancer. My primary clinical and research focus is on thyroid cancers and squamous cell carcinomas of the head and neck.
I also have an interest in diagnosing and treating the less common cancers of the head and neck, such as sinonasal undifferentiated carcinomas and salivary gland tumors.
Read more
Much of my research focuses on targeted therapy in the treatment of thyroid cancers (differentiated thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer). I work very closely with Memorial Sloan Kettering researchers working in areas such as radiation oncology, endocrinology, nuclear medicine, pathology, and head and neck surgery to investigate novel treatment options for patients with cancers of the head and neck, or thyroid.
Our group — the Head and Neck Oncology Service — is specifically interested in what makes tumors (both primary and acquired) resistant to treatments, and in finding ways to overcome this resistance.
I am currently an investigator and principal investigator on multiple studies in head and neck cancer both at Memorial Sloan Kettering Cancer Center and nationally. I also serve on the Steering Committee for the Radiation Therapy Oncology Group (RTOG), a National Cancer Institute–designated group composed of local and academic oncology centers and designed to facilitate clinical testing of radiation therapy and new drugs throughout the country.
A head and neck oncologist is a cancer doctor with special training in head and neck cancers. This includes cancers of the larynx, lips, mouth, nose, salivary glands, and throat.
My Specialties
- Head and Neck Cancer
- Thyroid Cancer
Education
- MD, Columbia University
Residencies
- Internal Medicine - Bellevue Hospital/New York University
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Sherman sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Sherman
- A Phase 2 Study of FORE8394 in People Who Have Cancer With BRAF Mutations
- A Phase 2 Study of Nivolumab and Ipilimumab Immunotherapy With or Without Cabozantinib for Advanced Nasopharyngeal Cancer
- A Phase I/II Study of LYT-200 in People with Solid Tumors
- A Pilot Study of Cemiplimab Immunotherapy Combined with Dabrafenib and Trametinib in People with Persistent Anaplastic Thyroid Cancer
Read more
- Clinical Trials Co-Investigated by Dr. Sherman
- A Phase 1 Study of TILT-123 Plus Avelumab in People With Advanced Solid Tumors
- A Phase 2 Study of Ozuriftamab Vedotin in People With Advanced Head and Neck Cancer
- A Phase 2 Study of Xevinapant With Chemotherapy and Radiation Therapy After Surgery in People With Head and Neck Cancer
- A Phase I Study of BCA101, Alone and Combined with Pembrolizumab Immunotherapy, in People with Advanced Lung Cancer
- A Study Assessing Cell-Free Tumor DNA Testing to Decide When to Start Routine Treatment in People with Human Papilloma Virus (HPV)-Associated Oropharynx Cancer
- A Study of Significantly Reduced Radiation Therapy and Reduced Chemotherapy in People with HPV-Positive Throat Cancer
- A Study to Assess Decreasing Radiation Therapy and Chemotherapy in People with Head and Neck Cancer
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Eric J. Sherman discloses the following relationships and financial interests:
-
Affyimmune Therapeutics, Inc.
Professional Services and Activities -
Blueprint Medicines
Professional Services and Activities -
Eisai
Professional Services and Activities
-
Eli Lilly and Company
Professional Services and Activities -
Exelixis
Professional Services and Activities -
Loxo Oncology
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].